Skip to content

Clinical trials

Myasthenia Gravis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: Canada Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20081
20091
20111
20131
20142
20154
20161
20172
20182
201911
20203
20217
20224
20233
20246
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting10
Recruiting9
Terminated7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx9
Alexion Pharmaceuticals, Inc.7
UCB Biopharma SRL6
University Health Network, Toronto4
Cartesian Therapeutics2
Grifols Therapeutics LLC2
Hoffmann-La Roche2
Immunovant Sciences GmbH2
Momenta Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis58
Autoimmune Diseases1
Multiple Sclerosis1
Nervous System Diseases1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating1
Thymoma1

Trials

Showing 26 to 50 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.